Latest Interviews
“One of our guiding principles is to be simultaneously global and local (glocal), which gives our clients a double advantage: A diversified portfolio and geographically optimum supplies from the cheapest markets,and an intimate understanding of local markets so as to gain the best arbitrage.”
59360
"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."
59358
"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."
59356
"We spent the past two years developing closer connections to our clients, vendors and clinical partners on a global scale."
59354
"Today, we have 96 customers in our network, ranging from very small virtual pharma companies to large, global pharma organizations."
59352
"In the past, we saw faster technology adoption by majors but today, we are witnessing the juniors realize the importance of these advancements and being part of industry 4.0."